Why Healthcare Organizations Are Choosing No-PHI Vendors

Most procurement decisions in healthcare involve a familiar set of trade-offs: feature set, price, integration complexity, support quality. For vendors that touch patient data, there is a category of cost that rarely appears on a comparison spreadsheet but can dwarf every other consideration — breach liability and BAA overhead.

A growing number of clinical workflow tools are being designed from the ground up to handle zero protected health information. The operational case for this architecture has become increasingly compelling.

Healthcare Leads Every Industry in Breach Cost — For the 14th Year

The IBM Cost of a Data Breach Report has tracked breach costs by industry since 2011. Healthcare has led every other sector for 14 consecutive years. In 2025, the average U.S. healthcare data breach cost $10.22 million — more than twice the global cross-industry average of $4.88 million. The average breach took 279 days to identify and contain.

At $408 per breached healthcare record, the per-record cost in healthcare is the highest of any industry tracked in the report. The reasons are structural: healthcare data is among the most sensitive personal information in existence, regulatory penalties are substantial, litigation exposure is significant, and remediation requires clinical operational disruption that other industries do not face.

In 2024, U.S. healthcare organizations reported 725 large breaches — nearly two every single day. Business associates, the third-party vendors that handle patient data on behalf of covered entities, were implicated in 34% of those breaches (HHS OCR, 2025). The vendor relationship is not a risk reduction strategy. In aggregate, it is a risk multiplication strategy.

The BAA as a Procurement Tax

Every vendor that handles protected health information requires a Business Associate Agreement. BAAs are not form documents — they involve legal review, security assessment, compliance verification, and contract negotiation that adds meaningful overhead to every vendor relationship.

Ironclad's 2025 contract intelligence data found that BAA execution averages 49 days from initiation to signature. For a health system adding four new clinical workflow vendors in a year, that is 196 days of legal and procurement work that produces no clinical output. It simply enables the vendor relationship to exist within HIPAA constraints.

The BAA overhead does not end at signing. It creates ongoing monitoring obligations, annual security review requirements, breach notification procedures, and termination protocols. Each BAA is a compliance relationship that must be actively maintained for as long as the vendor relationship exists.

No-PHI Architecture as a Structural Solution

A vendor that processes zero protected health information does not require a BAA. Full stop. There is no agreement to negotiate, no ongoing monitoring obligation, no breach notification pathway to establish, and no contribution to your organization's third-party vendor risk exposure.

The question is whether clinical tools can be genuinely useful while handling no patient data. For a meaningful category of workflows, the answer is yes. Formulary lookup is the clearest example: determining whether a drug is covered under a specific plan for a specific patient requires only the drug name and the plan name — neither of which is PHI. The patient's identity is irrelevant to the question. The answer is the same regardless of who is asking.

Drug interaction checking, formulary tier lookup, PA requirement identification, carve-out detection, coverage criteria review — none of these require patient data to return a clinically useful answer. They require drug and plan data, both of which are public.

What Procurement Looks Like Without a BAA Requirement

When a vendor requires no BAA, the procurement process compresses from months to days. There is no legal review queue. There is no security questionnaire. There is no waiting period for contract execution. The decision is functional: does the tool do what we need? If yes, access is immediate.

For tools that are deployed at the point of care — where a staff member needs an answer during a patient encounter — procurement speed is a clinical consideration, not just an administrative one. A tool that takes four months to clear procurement may be solving a problem that has already cost the practice hundreds of staff hours by the time it is deployed.